When the numbers don’t add up…
Last week I wrote about the emerging evidence on the consequences for public health of fiscal austerity in Europe.
Regulation
Warning: Austerity Can Seriously Damage Your Health
Leaders in health policy and finance are meeting this week in Oslo to debate the health consequences of the economic crisis, under the auspices of a WHO Europe conference. It’s about time. Whilst the economic pros and cons of austerity have been hotly debated in the media the real, human effects of so-called ‘fiscal consolidation’ can sometimes get lost in the noise and econononsense.
New R&D Models and Regulatory Measures in Support of Innovation: CASMI Takes on the Challenge
Taking a breakthrough in medicines development and translating it into tangible benefits for patients is not easy. In the current climate, the process that takes a medicine from petri dish to patient is increasingly cumbersome, as research methods and regulatory bodies have failed to keep up with scientific advances.
Healthcare Coalition on Data Protection calls for EU Data Protection Regulation to recognise the essential role of personal data in healthcare
Brussels– 29 January 2013 - Today the Healthcare Coalition on Data Protection published a joint statement highlighting the role of personal data in delivering high quality, patient-centred healthcare and conducting effective clinical and public health research, while expressing concerns on the potential negative impact of the proposed EU General Data Protection Regulation in these areas.
This Healthcare Coalition was recently formed and includes several key stakeholders active in the healthcare and related sectors in Europe.
EPAA Annual Conference 2012 - Global Cooperation on alternatives (3Rs) to animal testing
Being aware that alternatives to animal testing can only turn into a real success if implemented globally, it was been decided that the lead theme of the 2012 EPAA activities – and, consequently, that of the 2012 Annual Conference would be on the “development and Implementation of 3R methodologies through International Cooperation”.
Certificate in Healthcare Compliance Ethics & Regulation
Paris, 12-16 November 2012
EPAA 3Rs Communication Prize: Call for submissions
Deadline 15th October 2012
EPAA is offering a €3000 prize for an essay or article that shows awareness of the importance to promote alternative approaches in safety assessment and regulatory compliance testing. As this year the EPAA’s lead theme is “Global implementation of 3Rs methodologies through international cooperation” the article is expected to focus on existing and to be developed international initiatives on 3Rs in animal testing. Deadline for submissions is 15th October 2012.
Patients' W.A.I.T. Indicator - Report 2010
The latest edition shows that, depending on the patients' country of residence, doctors would be able to prescribe between 39% and 86% of the new medicines with a valid EU marketing authorisation granted between 1 January 2007 and 31 December 2009. For those new medicines that doctors can prescribe under the national healthcare provisions, average time elapsing between the date of EU market authorisation and the "accessibility" date in 14 European countries will vary from 88 to 392 days.
Presentations from EFPIA 2012 Annual meetings now available online
The public conference “Working Together for Europe’s Future” and the Educational Symposium “Healthcare Revolution with the New Science” took place on 27 June and aimed respectively to explore the challenges facing the industry as Europe seeks to emerge from the austerity crisis and the most recent developments in science and its impact on medical research and development.
"Reform of EU Clinical Trials Rules - Europe can’t afford to fail!", says Richard Bergström.
EFPIA welcomes the proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use adopted today by the European Commission as a first step towards further cooperation in the clinical trials assessment process across the EU.
